Sentia Medical Sciences, Inc.
  • About Us
  • Science & Technology
  • Disease Areas
  • News
  • Contact

News

Archive for the ‘Press Releases’ Category

Sentia Medical Sciences and Neurocrine Biosciences Extend Research Collaboration to Discover Novel CRF Peptides

February 14, 2023

READ MORE

Sentia Medical Sciences and Neurocrine Biosciences Enter into Strategic Collaboration to Discover Novel CRF Peptides

April 27, 2021

READ MORE

Sentia Medical Sciences Inc. Announces Bente Hansen Ph.D. to Join Sentia Board

September 18, 2020

READ MORE

Sentia announces the Passing of Founder, Professor Jean E. Rivier, at the age of 78

November 18, 2019

READ MORE

Sentia Medical Sciences Inc. Awarded Approximately $1.8 million Phase II Small Business Innovation Research (SBIR) Grant to Develop Astressins for the Treatment of Irritable Bowel Syndrome (IBS)

May 22, 2019

READ MORE

Sentia Medical Sciences Inc. Appoints Dr. Yvette Taché as Chair of the Scientific Advisory Board and Announces Award of a Phase 1 Small Business Innovation Research (SBIR) Grant to Develop Astressins for the Treatment of Irritable Bowel Syndrome (IBS)

June 12, 2018

READ MORE

Sentia Medical Sciences Inc. Announces the Launch of a New Initiative in Stress-related Disorders Targeting Gastrointestinal and Endocrine Diseases

November 17, 2017

READ MORE

Archives

  • 2023
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
Sentia Medical Sciences, Inc.
  • About Us
  • Science & Technology
  • Disease Areas
  • News
  • Contact

Copyright © Sentia Medical Sciences, Inc. | Terms & Conditions | Web design by ashwebstudio